Alnylam Pharmaceuticals, Inc. ( ALNY) - Key Metrics

ALNY Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $9.69 $1.23 $0.57 $0.31
2026Q1 $8.78 $1.55 $0.53 $0.37
2025Q4 $8.30 $1.41 $1.24 $1.06
2025Q3 $9.50 $1.91 $2.47 $2.38
2025Q2 $5.97 -$0.51 $1.19 $1.08

ALNY Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 61.18
2026Q1 0% 53.37
2025Q4 0% 70.51
2025Q3 0% 59.69
2025Q2 0% -159.85

ALNY Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 0.10% 0%
2026Q1 0.11% 0%
2025Q4 0.27% 0%
2025Q3 0.52% 0%
2025Q2 0.33% 0%

ALNY

Price: $255.36

52 week price:
197.81
495.55

Earnings Per Share: 5.72 USD

P/E Ratio: 38.29

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 712302

Ebitda: -143.6 million

Market Capitalization: 35.6 billion

Links: